Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TYMS | P04818 | 5/20 | 0.52 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.50 |
| ▸ | BCL2 | P10415 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | TERT | O14746 | 4/20 | 0.37 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
| ▸ | STAT3 | P40763 | 1/20 | 0.35 |
| ▸ | CDC25A | P30304 | 1/20 | 0.34 |
| ▸ | CDC25B | P30305 | 1/20 | 0.34 |
| ▸ | CDC25C | P30307 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30606666 | 1.00 | TYMS (0.52) | TYMSALOX15TDP1BCL2MEN1 | |
| SCHEMBL36626 | 1.00 | TYMS (0.52) | TYMSALOX15TDP1BCL2MEN1 | |
| SCHEMBL31185814 | 1.00 | TYMS (0.52) | TYMSALOX15TDP1BCL2MEN1 | |
| SCHEMBL29349446 | 1.00 | TYMS (0.52) | TYMSALOX15TDP1BCL2MEN1 | |
| SCHEMBL148025 | 0.89 | TYMS (0.62) | TYMSALOX15TDP1MEN1POLB | |
| SCHEMBL12680819 | 0.87 | TYMS (0.43) | TYMSALOX15TDP1BCL2MEN1 | |
| SCHEMBL13602782 | 0.87 | TYMS (0.43) | TYMSALOX15TDP1BCL2MEN1 | |
| SCHEMBL22142591 | 0.87 | TYMS (0.43) | TYMSALOX15TDP1BCL2MEN1 | |
| SCHEMBL30904850 | 0.87 | TYMS (0.63) | TYMSALOX15TDP1MEN1POLB | |
| SCHEMBL1189046 | 0.87 | TYMS (0.63) | TYMSALOX15TDP1MEN1POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8569500-B2 | Terrylene and quaterrylene derivatives | BASF AKTIENGESELLSCHAFT (DE) | 2013-10-29 | — | — | US | disclosed |
| US-20100317876-A1 | TERRYLENE AND QUATERRYLENE DERIVATIVES | BASF AKTIENGESELLSCHAFT (DE) | 2010-12-16 | — | — | US | disclosed |
| US-7795431-B2 | such as N-(2,6-Diisopropylphenyl)-1,6,9,14-tetra[4-(1,1,3,3-tetramethylbutyl)phenoxy]terrylene-3, 4:11,12-tetracarboxylic monoimide monoanhydride, used as dyes, as infrared absorbers, as semiconductors in organic electronics, emitters in electro- and chemiluminescence applications and in photovoltaics | BASF AKTIENGESELLSCHAFT (DE) | 2010-09-14 | — | — | US | disclosed |
| US-20080255357-A1 | Terrylene and Quaterrylene Derivatives | BASF AKTIENGESELLSCHAFT (DE) | 2008-10-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080255357-A1 | Terrylene and Quaterrylene Derivatives | GSTO1, TXN, XPA | TYMS 3248/4885ALOX15 168/4885TDP1 3861/4885 |
| US-20100317876-A1 | TERRYLENE AND QUATERRYLENE DERIVATIVES | GSTO1, TXN, XPA | TYMS 3248/4885ALOX15 168/4885TDP1 3861/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.